Su1937 PREDICTORS OF PROGNOSIS AND OUTCOMES AFTER DISCONTINUATION OF FIRST-USE BIOLOGICS IN IBD PATIENTS WITH AT LEAST 24 MONTHS FOLLOW-UP
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI